All In Biotech

Drug Trial Radar · NCT06869551

A Study to Evaluate the Drug Levels, Efficacy, and Safety of Deucravacitinib (BMS-986165) in Pediatric Participants With Juvenile Psoriatic Arthritis

A Phase 3, Multicenter, Double-blind, Placebo-controlled, Randomized Withdrawal Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of Deucravacitinib in Children and Adolescents From 5 to Less Than 18 Years of Age With Active Juvenile Psoriatic Arthritis

Last checked: Nov 20, 2026Latest source record: Oct 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

60

Planned (sponsor's estimate)

Start

Mar 13, 2025

Primary completion

Mar 6, 2030

Study completion Mar 4, 2031

Sponsor

Lead sponsor
Bristol-Myers SquibbBristol Myers Squibb (BMY)
Sponsor type
Industry
First posted
Mar 11, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 5 years, up to 17 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the drug levels, efficacy, and safety of Deucravacitinib (BMS-986165) in pediatric participants with juvenile psoriatic arthritis.

Conditions

  • Juvenile Psoriatic Arthritis

Interventions

  • DeucravacitinibDrug

    Specified dose on specified days

  • PlaceboOther

    Specified dose on specified days

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Time to first flare during the withdrawal periodTime frame: From week 16 up to week 42

Locations

48 sites in 11 countries. Site status is shown where the registry gives one.

  • Local Institution - 0038

    Lancaster, California · Withdrawn

  • Local Institution - 0020

    Chicago, Illinois · Withdrawn

  • Local Institution - 0023

    Indianapolis, Indiana · Withdrawn

  • Local Institution - 0059

    North New Hyde Park, New York · Withdrawn

  • Local Institution - 0065

    Cincinnati, Ohio · Withdrawn

  • Local Institution - 0066

    Cleveland, Ohio · Withdrawn

  • Local Institution - 0036

    Austin, Texas · Withdrawn

  • Local Institution - 0027

    Rio de Janeiro, Brazil · Not yet recruiting

  • Santa Casa Instituto de Pesquisa

    São Paulo, Brazil · Recruiting

  • Local Institution - 0010

    São Paulo, Brazil · Withdrawn

  • Centro de Oncologia Leonardo Da Vinci - ATO Terapias

    Fortaleza, Ceará, Brazil · Recruiting

  • Local Institution - 0032

    Cuiabá, Mato Grosso, Brazil · Withdrawn

  • Santa Casa de Misericordia de Belo Horizonte

    Belo Horizonte, Minas Gerais, Brazil · Recruiting

  • Hospital Pequeno Príncipe / Associação Hospitalar de Proteção à Infância

    Curitiba, Paraná, Brazil · Recruiting

  • Local Institution - 0013

    Curitiba, Paraná, Brazil · Withdrawn

  • Hospital Das Clinicas Ufpe

    Recife, Pernambuco, Brazil · Recruiting

  • Local Institution - 0033

    Porto Alegre, Rio Grande do Sul, Brazil · Withdrawn

  • LMK Serviços Médicos S/S

    Porto Alegre, Rio Grande do Sul, Brazil · Recruiting

  • Hospital Lifeplus Litoral Norte

    Xangri-lá, Rio Grande do Sul, Brazil · Recruiting

  • PSEG- Pesquisa Clínica

    Vila Clementino, São Paulo-SP, Brazil · Recruiting

  • University Multiprofile Hospital for Active Treatment "Sveti Georgi" EAD

    Plovdiv, Bulgaria · Recruiting

  • Medical Center for Specialized Medical Care of Cardiovascular Diseases

    Sofia, Bulgaria · Recruiting

  • Local Institution - 0062

    Sofia, Bulgaria · Withdrawn

  • Children's Hospital of Fudan University

    Shanghai, China · Recruiting

  • Local Institution - 0074

    Beijing, Beijing Municipality, China · Not yet recruiting

  • Local Institution - 0049

    Beijing, Beijing Municipality, China · Not yet recruiting

  • The Children's Hospital of Chongqing Medical University

    Chongqing, Chongqing Municipality, China · Recruiting

  • Guangzhou Women and Children's Medical Center

    Guangzhou, Guangdong, China · Recruiting

  • Childrens Hospital of Nanjing Medical University

    Nanjing, Jiangsu, China · Recruiting

  • The First Hospital of Jilin University

    Changchun, Jilin, China · Recruiting

  • The Children's Hospital of Zhejiang University School of Medicine

    Hangzhou, Zhejiang, China · Recruiting

  • Fakultni nemocnice Olomouc

    Olomouc, Olomouc Region, Czechia · Recruiting

  • Fakultni nemocnice v Motole

    Prague, Praha 5, Czechia · Recruiting

  • Kinderklinik des Uni-Klinikums Erlangen

    Erlangen, Germany · Recruiting

  • Praxis Kinder- und Jugendrheumatologie Dr. Ivan Foeldvari

    Hamburg, Germany · Recruiting

  • University of Naples Federico II

    Naples, Campania, Italy · Recruiting

  • Azienda Ospedaliera Universitaria Meyer IRCCS

    Florence, Tuscany, Italy · Recruiting

  • Local Institution - 0017

    San Juan, Puerto Rico · Withdrawn

  • Spitalul Clinic de Urgenta pentru Copii Cluj-Napoca

    Cluj-Napoca, Cluj, Romania · Recruiting

  • Local Institution - 0048

    Iași, Iaşi, Romania · Withdrawn

Showing 40 of 48 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.